ISSUE BRIEF: Biopharma Drug Makers Are Not the Most Profitable Players in Health Care
A new issue brief released by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute finds that innovative drug manufacturers earn some of the lowest risk-adjusted returns in the U.S. health care system, despite making the ...
Watch PRI’s interview with Rick Caruso – one year after the wildfires
In this special Free Cities Center interview, Rick Caruso – founder and executive chairman of Caruso, longtime civic and philanthropic leader in Los Angeles and former mayor candidate – discusses LA’s rebuilding efforts one year after the wildfires. He shares ...
We Should Call February 20th Tariff Liberation Day
This decision will limit one of the Administration’s major anti-growth policies. The immediate benefits will be muted because, also as expected, President Trump is pushing alternate ways to try and raise tariffs. He has announced, under another statute, that he ...
Hospitals Turn a Safety-Net Program Into an ATM
Washington, D.C. is finally taking a hard look at one of the most abuse-ridden federal health programs — the 340B Drug Pricing Program. Last week, the Trump administration released a request for information exploring ways to bring more transparency and ...
How Trump’s ‘Prior Authorization’ Deal Puts Patients Ahead of Paperwork
Americans increasingly need a permission slip from their insurance company before they can get medical care. And it’s driving them crazy. According to one recent survey, nearly three-quarters of patients find delays and denials of treatment by insurers to be ...
Trending Topics
- Most Popular
- Crime
- Drug Importation
- Drug Innovation
- Homelessness
- Inflation
- Single Payer
Arizona Republicans should stop trying to ban mRNA vaccines
Despite Democratic Governor Hobbs’ past efforts to expand Arizonans’ access to cutting-edge medicines, the state Legislature continues to propose harmful anti-mRNA bills. The latest example ...
Cancer Breakthroughs Threatened by D.C.’s Price Controls
Cancer survival rates are on the rise, according to the American Cancer Society’s latest annual report. Seven in 10 patients now live five years or ...
Sorry, but single-payer won’t fix American health care
Affordability is becoming the watchword for Republicans and Democrats alike this election year. Progressives in Senate races from Maine to Illinois to Minnesota are putting ...
About PRI
The Pacific Research Institute for Public Policy promotes the principles of individual freedom and personal responsibility. The Institute believes these principles are best encouraged through policies that emphasize a free economy, private initiative, and limited government.
Worthy policy goals with such broad impact are not easily attained, and they require sustained effort and struggle. Together with its alliance of dedicated supporters, PRI is committed to leading the way toward a more free and prosperous future for all.
2024 By the Numbers
Op-Eds
0
Hosted Events
0
Books, Studies, Videos
0
Print and Online Media Hits
0
